Risk assessment in patients with PAH in the era of COVID-19 and the telehealth revolution
Patients affected by pulmonary arterial hypertension (PAH) benefit from intensive, continuous clinical monitoring to guide escalation of treatments that carry the potential to improve survival and quality of life. During the COVID-19 pandemic, the need for physical distancing has fueled the expeditious expansion of various telehealth modalities, which may apply in a unique manner to individuals with PAH. Performance of objective risk assessments in patients with PAH remotely via telemedical visits and other telehealth mechanisms is unprecedented and not yet rigorously validated.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: M. Wesley Milks, Sandeep Sahay, Raymond L. Benza, Harrison W. Farber Tags: State of the art review Source Type: research
More News: Cardiology | COVID-19 | Heart | Heart Transplant | Hypertension | Lung Transplant | Pandemics | Transplant Surgery | Transplants